Status:
COMPLETED
Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Inflammatory Breast Cancer
Eligibility:
All Genders
Brief Summary
One form of breast cancer, known as inflammatory breast cancer (IBC), is characterized by diffuse erythema (redness) and edema (peau d'orange) of the breast. This type of cancer is aggressive and poor...
Detailed Description
Breast cancer characterized by diffuse erythema and edema, or peau d'orange, of the breast (inflammatory breast cancer (IBC)) is rare, particularly aggressive, and poorly understood. The extent of red...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- All patients with redness and edema or peau d'orange, of the breast who are seen at the National Cancer-Cairo, Egypt or the Institute Salah Azair in Tunis, Tunisia during the period June 1, 2004 to May 31, 2005 will be eligible for the pilot study.
Exclusion
Key Trial Info
Start Date :
September 8 2004
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00344071
Start Date
September 8 2004
Last Update
July 2 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University Hospital
Cairo, Egypt
2
National Cancer Institute-Cairo
Cairo, Egypt
3
Association Tunisienne de lutte contre le Cancer (ATCC, le conseil
Tunis, Tunisia
4
Charles Nicolle Hospital, Tunisia
Tunis, Tunisia